Clinical Significance of Topoisomerase-II Expression in Patients with Non-Small Cell Lung Cancer Treated with Amrubicin

被引：0
|
作者：
Sakurai, R. [1 ]
Kaira, K. [2 ]
Miura, Y. [1 ]
Tomizawa, Y. [3 ]
Tsukagoshi, Y. [1 ]
Masuda, T. [1 ]
Kasahara, N. [1 ]
Sunaga, N. [4 ]
Saito, R. [3 ]
Hisada, T. [1 ]
机构：
[1] Gunma Univ Hosp, Div Allergy & Resp Med, Maebashi, Gunma, Japan
[2] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gunma, Japan
[3] Natl Hosp Org Shibukawa Med Ctr, Div Resp Med, Shibukawa, Japan
[4] Gunma Univ Hosp, Oncol Ctr, Maebashi, Gunma, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
topoisomerase-II; Amrubicin; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-027
引用
收藏
页码：S2078 / S2078
页数：1
相关论文
共 50 条
  • [21] Prognostic significance of dysadherin expression in patients with non-small cell lung cancer
    Tamura, M
    Ohta, Y
    Tsunezuka, Y
    Matsumoto, I
    Kawakami, K
    Oda, M
    Watanabe, G
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (03): : 740 - 745
  • [22] The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients
    Kadota, Kyuichi
    Huang, Cheng-long
    Liu, Dage
    Ueno, Masaki
    Kushida, Yoshio
    Haba, Reiji
    Yokomise, Hiroyasu
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (07) : 1057 - 1067
  • [23] Effect of Amrubicin in Patients with Previously Treated Non-Small-Cell Lung Cancer
    Takayama, S.
    Tamura, T.
    Kawajiri, T.
    Nishi, T.
    Kudo, K.
    Kuyama, S.
    Kawakado, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S937 - S937
  • [24] Clusterin immuno-expression and its clinical significance in patients with non-small cell lung cancer
    Li, H.
    Zhu, X.
    Liu, S.
    Xiang, J.
    Chen, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients
    Lu, Baohua
    Zhang, Hongmei
    Zhang, Tongmei
    Cai, Yiran
    Hu, Ying
    Zheng, Hua
    Li, Baolan
    THORACIC CANCER, 2016, 7 (04) : 486 - 494
  • [26] Phase I/II Study of Amrubicin and Nedaplatin in Patients with Untreated, Advanced, Non-Small Cell Lung Cancer
    Ogawara, Daiki
    Nakamura, Yoichi
    Fukuda, Minoru
    Nakatomi, Katsumi
    Yamaguchi, Hiroyuki
    Motoshima, Kohei
    Mizoguchi, Kosuke
    Nakano, Hirofumi
    Takemoto, Shinnosuke
    Gyotoku, Hiroshi
    Nagashima, Seiji
    Kohno, Shigeru
    CHEMOTHERAPY, 2014, 60 (03) : 180 - 184
  • [27] Clinical significance of Girdin expression detected by immunohistochemistry in non-small cell lung cancer
    Song, Jing-Ying
    Jiang, Ping
    Li, Ning
    Wang, Feng-Hua
    Luo, Jun
    ONCOLOGY LETTERS, 2014, 7 (02) : 337 - 341
  • [28] The Expression and Clinical Significance of α-tubulin in 91 Cases Non-Small Cell Lung Cancer
    Gao, Sujun
    Li, Zhi
    Liu, Qingsong
    Liu, Wei
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S393 - S394
  • [29] Expression and clinical significance of timeless, RORA, and MYADM in non-small cell lung cancer
    Bian, Lixia
    Sun, Yanjun
    Miao, Jiefei
    Sun, Zuhua
    Liu, Yifei
    MINERVA SURGERY, 2024,
  • [30] Maspin Expression and Its Clinical Significance in Non-Small Cell Lung Cancer.
    Park, S. K.
    Seol, H. Y.
    Jo, W. H.
    Kim, J. E.
    Jeon, D. S.
    Kim, K. U.
    Park, H. K.
    Kim, Y. S.
    Lee, M. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345